Conmed reports Q2 adjusted EPS $1.15, consensus $1.12

Reports Q2 revenue $342.3M, consensus $338.42M. “We are encouraged by our second quarter performance as we focused on building a stronger operational foundation,” commented Patrick J. Beyer, CONMED’s (CNMD) President and Chief Executive Officer. “We continue to strengthen our supply chain operations with a focus on turning this into an area of strength within CONMED. We remain very confident in the long-term potential of our four key growth drivers and the solid foundation for sustained revenue and earnings growth that they provide.”